Asthma: open trials in Slovakia

9 open trials have a site in Slovakia. Registry data; only the trial team decides who can take part.

NCT07359846
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Trial Treatment · Phase 3 · Generate Biomedicines
Košice · Košice · Spišská Nová Ves
Registry updated 2026-11-03
NCT05776927
A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Bratislava · Košice
Registry updated 2026-10-15
NCT07323654
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Trial Treatment · Phase 2 · Kymera Therapeutics, Inc.
Bardejov · Košice · Spišská Nová Ves
Registry updated 2026-10-06
2026-526241-98-00
A Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
Trial Treatment · Phase 2 · Kymera Therapeutics Inc.
ALIAN s.r.o., Bardejov · Alersa s.r.o., Košice · Plucna ambulancia Hrebenar S.R.O., Spišská Nová Ves
Registry updated 2026-09-23
2025-523180-38-00
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
Trial Treatment · Phase 2 · Kymera Therapeutics Inc.
ALIAN s.r.o., Bardejov · Nsp Sv. Jakuba N.O. Bardejov, Bardejov · Alersa s.r.o., Košice · Plucna ambulancia Hrebenar S.R.O., Spišská Nová Ves
Registry updated 2026-09-03
2025-524040-35-00
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
Trial Treatment · Phase 3 · Generate Biomedicines Inc.
ALIAN s.r.o., Bardejov · Zeleznicne zdravotnictvo Kosice s.r.o., Kosice · Alersa s.r.o., Košice · Plucna ambulancia Hrebenar S.R.O., Spišská Nová Ves
Registry updated 2026-08-05
2022-502365-26-00
A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.
Trial Treatment · Phase 3 · Novartis Pharma AG
Detska fakultna nemocnica s poliklinikou Banska Bystrica, Banská Bystrica · Narodny ustav detskych chorob, Bratislava · JOCIA s.r.o., Bratislava · Alersa s.r.o., Košice · Medimun s.r.o., Trnava
Registry updated 2026-08-04
NCT07666490
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Trial Treatment · Phase 4 · Chiesi Farmaceutici S.p.A.
ALIAN s.r.o., Bardejov · Rockmed s.r.o., Bratislava · Zeleznicne zdravotnictvo Kosice s.r.o., Kosice · Plucna ambulancia Hrebenar S.R.O., Spišská Nová Ves
Registry updated 2026-07-31
NCT07301736
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
Trial Treatment · Phase 2 · Chiesi Farmaceutici S.p.A.
ALIAN s.r.o., Bardejov · Danimed spol. s r.o., Levice · Plucna ambulancia Hrebenar S.R.O., Spišská Nová Ves
Registry updated 2026-06-25

All Asthma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error